Your browser doesn't support javascript.
loading
Transition from intravenous epoprostenol to selexipag in pulmonary arterial hypertension: a word of caution.
Yanaka, Kenichi; Guillien, Alicia; Soumagne, Thibaud; Benet, Justin; Piliero, Nicolas; Picard, François; Pison, Christophe; Sitbon, Olivier; Bouvaist, Hélène; Degano, Bruno.
Afiliação
  • Yanaka K; Dept of Cardiology, Grenoble Alpes University Hospital, Grenoble, France.
  • Guillien A; Environmental Epidemiology applied to Reproduction and Respiratory Health, INSERM, CNRS, University Grenoble Alpes, Institute for Advanced Biosciences (IAB), U1209 Joint Research Center, Grenoble, France.
  • Soumagne T; Dept of Intensive Care Medicine, University Hospital, Besançon, France.
  • Benet J; Dept of Respiratory Medicine, University Hospital of Grenoble Alpes, Grenoble, France.
  • Piliero N; Dept of Cardiology, Grenoble Alpes University Hospital, Grenoble, France.
  • Picard F; Dept of Cardiology, Haut-Lévêque, Pessac, France.
  • Pison C; Dept of Respiratory Medicine, University Hospital of Grenoble Alpes, Grenoble, France.
  • Sitbon O; University Paris-Saclay, Le Kremlin-Bicêtre, France.
  • Bouvaist H; Dept of Respiratory Medicine, Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, France.
  • Degano B; INSERM, UMR_S999, Le Plessis-Robinson, France.
Eur Respir J ; 55(6)2020 06.
Article em En | MEDLINE | ID: mdl-32108046

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazinas / Epoprostenol / Hipertensão Arterial Pulmonar / Acetamidas / Anti-Hipertensivos Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazinas / Epoprostenol / Hipertensão Arterial Pulmonar / Acetamidas / Anti-Hipertensivos Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article